Eurofins and Celsis to provide rapid micro validation and screening services

摘要

Eurofins Lancaster Laboratories, a specialist in bio/pharmaceutical GMP product testing based in Lancaster, PA in the US, is to collaborate with Celsis International, a leader in rapid microbial detection systems, to provide more cost-effective validation and screening services. Under the agreement, Eurofins will provide contract rapid microbiology validation and screening services for the Celsis rapid detection technology platform. Celsis says its rapid detection system allows companies to ensure that their products meet microbial specification 60-80% faster than traditional methods, reducing production cycle times by seven to 10 days.